Saket Reddy
@saketreddy
Followers
52K
Following
77K
Statuses
20K
Business. Management. Reinvestment. Vision without execution is just hallucination
Joined March 2014
ANURAS Signs LOI with US MNC, for supply of High Performance Speciality Chemical Product used in critical Polymer applications. The supply of this product will span over next 10 years, with cumulative sales projected to reach $195 million (₹1,697 crores). Working on the development of this product for the last three years, investing significant time in trials and validation to ensure its performance meets the highest industry standards. Also signs $12.5 mn (~₹108 cr.) per annum Contract with US MNC. Supplying this specialized molecule for polymer applications further strengthens role in the aviation, electronics, and defence end applications.
0
0
5
RT @soumeet_sarkar: Venus Pipes In Focus Revenue up 12% YoY to Rs 231 cr Higher exports aided revenue growth Foray into fittings is posi…
0
1
0
RT @Restructuring__: Investing is fascinating because of the infinite ways to play the game On one hand, Bill Ackman highlights its robus…
0
8
0
RT @Nigel__DSouza: Mr.Nikhil Chopra, CEO & Whole-Time Director of #JBPharma 💊 Will maintain an #EBITDA margin of 26-28% for FY25 💊 Aims to…
0
5
0
RT @Nigel__DSouza: RHI Magnesita says 👏 Q3FY25 was a historic quarter with revenues at Rs.1000cr 🎯 Aim to hit market share of 40%, current…
0
2
0
RT @ClarkSquareCap: This is a fantastic list of resources if you're interested in emerging market investing: https…
0
35
0
"In animal health when a drug loses exclusivity, it might take five years to have an erosion of between 20% to 40%." In relatively immature animal health markets, the launch of a competing product can even bolster growth as compliance increases. From my Zoetis $ZTS report 👇
1
1
10
RT @PRATIKBULANI555: Numbers are improving for #Nykaa however, couple of things one should look for is the growth needs to remain intact if…
0
1
0
RT @JamieHalse: The Tokyo stock exchange could not be more clear about their game plan. This alone makes Japanese stocks interesting, but…
0
23
0